Free Trial

Procter & Gamble (NYSE:PG) Stock: Insider Andre Schulten Sells 3,914 Shares

Procter & Gamble logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • CFO Andre Schulten sold 3,914 Procter & Gamble shares at an average price of $145.34, totaling approximately $568,861. The sale covered tax-withholding obligations tied to vested equity awards, leaving him with 65,618 shares.
  • PG shares traded at $148.34, while the company reported quarterly EPS of $1.43, narrowly exceeding estimates, and revenue of $21.20 billion. Analysts have a “Moderate Buy” consensus rating with an average price target of $161.70.
  • Procter & Gamble maintains a shareholder-focused profile, paying a $1.0885 quarterly dividend, equivalent to a 2.9% yield and roughly $4.35 annually per share; institutional investors own 65.77% of the stock.
  • Five stocks to consider instead of Procter & Gamble.

Procter & Gamble Company (The) (NYSE:PG - Get Free Report) CFO Andre Schulten sold 3,914 shares of the company's stock in a transaction on Monday, October 5th. The shares were sold at an average price of $145.34, for a total value of $568,860.76. Following the completion of the sale, the chief financial officer owned 65,618 shares of the company's stock, valued at approximately $9,536,920.12. This trade represents a 5.63% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Procter & Gamble Price Performance

NYSE:PG traded up $2.40 during mid-day trading on Tuesday, reaching $148.34. 11,232,253 shares of the stock were exchanged, compared to its average volume of 9,677,071. The business has a fifty day moving average price of $145.67 and a 200 day moving average price of $145.97. The firm has a market capitalization of $344.55 billion, a PE ratio of 22.41, a PEG ratio of 3.60 and a beta of 0.39. Procter & Gamble Company has a 1-year low of $137.62 and a 1-year high of $167.25. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, beating analysts' consensus estimates of $1.41 by $0.02. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The company had revenue of $21.20 billion during the quarter, compared to the consensus estimate of $21.38 billion. During the same period in the prior year, the company earned $1.48 EPS. Procter & Gamble's revenue was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Research analysts expect that Procter & Gamble Company will post 6.98 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, August 17th. Investors of record on Friday, July 24th were paid a dividend of $1.0885 per share. The ex-dividend date of this dividend was Friday, July 24th. This represents a $4.35 annualized dividend and a yield of 2.9%. Procter & Gamble's dividend payout ratio is currently 65.71%.

Procter & Gamble News Summary

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: Evercore ISI upgraded PG and raised its price target to $166, adding to the bullish analyst outlook. Royal Bank of Canada also maintained an “outperform” rating, implying roughly 11.9% potential upside from the referenced price despite trimming its target modestly to $166 from $167. Evercore ISI upgrades Procter & Gamble and raises price target Royal Bank of Canada cuts Procter & Gamble price target
  • Positive Sentiment: Investor-focused coverage continues to highlight Procter & Gamble’s 70-year record of dividend increases, reinforcing its reputation as a reliable income and defensive consumer-staples holding. Procter & Gamble dividend reliability article
  • Neutral Sentiment: Procter & Gamble will webcast its 2026 virtual annual shareholder meeting on October 13, providing a possible venue for updates on strategy, capital allocation and business trends. Procter & Gamble 2026 virtual annual meeting
  • Neutral Sentiment: Recent commentary compares PG with other household-products companies and frames it as a relatively defensive, dividend-oriented performer, though the articles provide limited new company-specific operating information. Procter & Gamble versus household-products stocks
  • Negative Sentiment: Investors are preparing for Procter & Gamble’s first-quarter results later this month, with analysts anticipating a single-digit year-over-year decline in earnings. That expectation could limit near-term upside and increase focus on pricing, volume and guidance. Procter & Gamble earnings preview

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on PG shares. Barclays increased their price objective on Procter & Gamble from $146.00 to $152.00 and gave the company an "equal weight" rating in a research report on Tuesday, July 21st. Citigroup decreased their target price on Procter & Gamble from $181.00 to $170.00 and set a "buy" rating on the stock in a report on Thursday, July 30th. TD Cowen reaffirmed a "hold" rating and set a $150.00 target price on shares of Procter & Gamble in a report on Wednesday, September 30th. Sanford C. Bernstein reiterated a "market perform" rating and issued a $149.00 price target on shares of Procter & Gamble in a research report on Monday, August 24th. Finally, Royal Bank Of Canada dropped their price target on Procter & Gamble from $167.00 to $166.00 and set an "outperform" rating on the stock in a research note on Tuesday. Fourteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company's stock. According to data from MarketBeat, Procter & Gamble presently has an average rating of "Moderate Buy" and an average target price of $161.70.

Read Our Latest Analysis on Procter & Gamble

Institutional Trading of Procter & Gamble

Several large investors have recently added to or reduced their stakes in PG. BlackRock Inc. acquired a new position in Procter & Gamble during the second quarter valued at $27,862,105,000. State Street Corp boosted its position in Procter & Gamble by 1.0% during the 2nd quarter. State Street Corp now owns 102,216,308 shares of the company's stock worth $14,988,999,000 after acquiring an additional 965,461 shares during the period. Bank of America Corp DE purchased a new position in Procter & Gamble during the 2nd quarter valued at about $3,850,628,000. Franklin Resources Inc. increased its holdings in shares of Procter & Gamble by 4.5% in the 4th quarter. Franklin Resources Inc. now owns 23,872,178 shares of the company's stock valued at $3,421,122,000 after purchasing an additional 1,021,833 shares during the period. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Procter & Gamble in the second quarter worth approximately $2,281,505,000. 65.77% of the stock is owned by institutional investors and hedge funds.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company NYSE: PG is a consumer products company that develops, manufactures and markets branded products used in households and personal care routines. Its portfolio includes products in categories such as beauty, grooming, health care, fabric and home care, and family care.

Major brands associated with Procter & Gamble include Pampers, Tide, Gillette, Head & Shoulders, Pantene, Oral-B, Crest, Olay, Old Spice, Febreze, Mr. Clean, Swiffer and Bounty. The company sells its products through retailers, e-commerce platforms and other distribution channels.

Founded in Cincinnati, Ohio, in 1837 by William Procter and James Gamble, the company has grown into a global consumer goods business serving customers in markets around the world.

Recommended Stories

Insider Buying and Selling by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines